32 /100
MEDIUM RISK
Score updated May 30, 2026

ANEB — Anebulo Pharmaceuticals, Inc. Dilution Risk Tracker

Track ANEB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANEB — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
32%
🔄 Reverse Split 55%
• 50-day avg $0.60 below $1 exchange minimum
📉 Score Deterioration 15%
• Score climbed 8 points (worsening)
🔔 Track ANEB — Get forecast alerts →

💹 Market Data

Market Cap$19.17M
Shares Outstanding40.78M
Float24.13M
Cash$9.04M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 0.0% shares (2025Q4 vs prior)
19 institutional holders · 22.21M shares
#1 22NW, LP 15.47M shares
#2 Nantahala Capital Management, LLC 3.04M shares
#3 MANGROVE PARTNERS IM, LLC 2.53M shares
+ 16 more holders Sign up free to view →

📉 Short Interest

Short Interest5.8K
Days to Cover1.3
% of Float0.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jun 30, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ANEB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANEB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ANEB
📊 ANEB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ANEB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.